Express Pharma

Biochemize and Polyclone sign MoU

0

To offer enzyme engineering services

Spain-based Biochemize and Bengaluru-based Polyclone have signed a Memorandum of Understanding (MoU) to collaborate in the field of enzyme engineering. This collaboration came about as a result of the European Business and Technology Centre (EBTC) EU-India biotechnology mission last year, where a partnering session was organised to foster EU-India business and research relationships.

Biochemize is a biotechnology company focused on the design and development of processes based on biocatalysis and microbial fermentation for the manufacturing of active pharmaceutical ingredients (APIs).The MoU with Polyclone Bioservices will utilise Polyclone’s in silico enzyme engineering framework (eEF) to strengthen its core services.

Leave A Reply

Your email address will not be published.